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The effect of ascorbic acid on renal function in dogs subjected to ischemia reperfusion 
injury was investigated. Six dogs with a mean weight of 10 kg (range 8 - 11 kg) were 
used in the study. The dogs were administered ascorbic acid (treatment group) and the 
same volume of normal saline (control group).This administration was followed by 
reperfusion. Nephrectomy was carried out on the right kidneys. Blood samples were 
collected from these dogs post operatively on days 1, 3, 5, 7, 10, and 14 days and 
analysed for blood urea (BUN) and creatinine. There was no significant difference in 
serum creatinine level in both the control and treatment group (p>0.05). There was 
significant change in the levels of BUN in both the control and treatment groups 
(p<0.05). In conclusion, ascorbic acid protects renal tissue from being damaged by 
ischemia-reperfusion injury, thereby, helping in the recovery of renal function.   
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INTRODUCTION 
The occurrence of hemorrhage during and 
after surgical procedures is considered a 
complication which could affect the 
overall outcome of surgical interventions. 
During surgery, variety of measures are 
taken to prevent hemorrhage, prominent 
among which is the clamping of blood 
vessels. This cut off the blood supply to 
the tissues supplied by these vessels and 
creates ischemic injury. On restoration of 
blood supply to such tissues (reperfusion) 
more severe tissue injury occurs (Jefayri et 
al., 2000).The absence of oxygen and 
nutrients from blood creates a condition in 
which the restoration of circulation results 
in inflammation and oxidative damage 
through the induction of oxidative stress 
rather than restoration of normal function. 
This phenomenon has been shown to cause 
both local and systemic organ dysfunction 
(Fridovic, 1979). 
 
Ischemia reperfusion injury is mediated by 
oxygen free radicals produced from the 
biochemical process which takes place 
when ischemic tissues are reperfused. The 
oxygen free radicals cause oxidative stress 
resulting in alterations in ability of the 
mitochondria to produce energy for the 
cells leading to a loss of cellular function 
and integrity (Sekhon et al., 2003). The 
damage of reperfusion injury is due in part 
to the inflammatory response of damaged 
tissues. White blood cells carried to the 
area by the newly returning blood release a 
host of inflammatory factors such as 
interleukins as well as free radicals in 
response to tissue damage (Wayne, 2005). 
 
Renal graft rejection and renal failure are 
associated with ischemia-reperfusion 
injury (Jae-il et al., 2006a). Attempt to 
reduce the effect of this phenomenon is 
expected to improve the chances of 
survival of renal transplant patients. 
 




The aim of this study is to investigate the 
effect of antioxidant ascorbic acid pre-
treatment on the damage caused to the 
kidney by the induction of renal ischemia 
followed by reperfusion in a dog model. 
 
 
MATERIALS AND METHODS 
Six adult local (mongrel) dogs, purchased 
from Agbowo Market in Ibadan, with a 
mean weight of 10 kg (range, 8 - 11 kg) 
were stabilized and subjected to renal 
function test were used for this study. The 
renal function test was performed by 
collecting urine sample through 
cystocentesis for urinalysis, and blood 
sample for creatinine and blood urea 
nitrogen analysis. 
The animals were divided into two groups 
of three dogs each (treatment and control 
groups). 
Group 1 (the treatment group) received 
ascorbic acid (an antioxidant) at 150 
mg/kg intravenously (i/v). 
Group 2 (the control group) received equal 
volume of normal saline intravenously 
similar to the treatment group. 
 
The dogs were pre-medicated with 
atropine sulphate at a dose rate of 0.04 
mg/kg body weight intramuscularly (i/m) 
and xylazine hydrochloride at a dose rate 
of 2 mg/kg body weight i/m . Anesthesia 
was induced and maintained with 
pentobabitone sodium (6 % solution) at a 
dose rate of 10 mg/kg body weight i/v. All 
dogs were administered lactated ringers 
solution 10 mls/kg/hour intravenously and 
ceftriaxone (30mg/kg i/v) as a prophylactic 
treatment before surgery. 
 
OPERATIVE PROCEDURE 
For each experimental animal, the skin of 
the ventral abdomen was shaved, scrubbed 
and prepared aseptically using medicated 
soap (Dettol
®
 soap) with water. The final 
scrubbing of the proposed surgical site was 
done using sterile gauze soaked in 
chlorhexidine solution. 
 
The patient was anesthetized and placed on 
dorsal recumbency. Endotracheal 
intubation was effected and secured. Skin 
drapes and surgical incision drapes were 
placed on the animal. A ventral midline 
abdominal incision was made from the 
xiphoid process through the umbilicus to 
the pubis. The left kidney was exposed by 
packing the bowel loops to the right side 
of the animal using the mesentery of 
descending colon. The left renal artery and 
vein (of the left kidney) were exposed by 
removing fat covering the kidney; 150 
mg/kg of ascorbic acid was injected 
intravenously through the cephalic vein to 
the treatment group. After 10 minutes, the 
left renal artery and vein were clamped for 
45 minutes after which the clamp was 
removed and blood flow to the kidney was 
restored. The right kidney was exposed by 
packing the intestinal loop to the left side 
of the animal using the mesentery of Ilium. 
The fat covering the kidney was removed. 
The renal artery was isolated and doubly 
ligated using 1-0 chromic catgut and 
transected. The vein was ligated and 
transected. The ureter was ligated and 
transected close to its insertion on the 
urinary bladder. Nephrectomy was 
affected.  
The abdominal incision was closed in three 
layers. The linea alba was closed with 
chromic catgut size 1-0, using simple 
interrupted suture pattern. The 
subcutaneous tissue was closed with 
subcuticular suture pattern using chromic 
catgut size 3-0. The skin was closed with 
nylon size 1-0 using simple interrupted 
horizontal mattress suture pattern. 
 
Blood samples were collected post 
operatively on days 1, 3, 5, 7, 10 and 14 
into blood sample bottles containing 
EDTA for blood urea nitrogen (BUN) and 
creatinine analysis using commercially 
available kit for the determination of the 
concentrations of blood urea nitrogen and 
creatinine in serum and plasma. 
 

















































The same procedure was repeated for the 
control group except that equal volumes of 
normal saline as the ascorbic acid used in 
the treated group were injected 
intravenously. 
 
The mean and standard deviation for each 
experiment was determined using ANOVA 
and the student t-test. Differences at 
p<0.05 were taken as statistically 
significant.  
 
POST OPERATIVE CARE 
The animals were returned to the kennels 
after recovering from anaesthesia and were 
allowed access to their normal ration of 
food and water. 
Ceftriaxone was administered for 3 days at 
a dose rate of 30 mg/kg i/m. Post operative 
pain was controlled with pentazocine (2 
mg/kg) i/m for three days. The skin sutures 




All the dogs used (treatment and control) 
demonstrated good renal function. The 
serum creatinine and BUN levels were 
measured as indices of renal function. The 
mean serum creatinine levels in the control 
group increased to 1.8±0.2 mg/dl (base 
line levels 0.8 ± 0.2 mg/dl) after 5 days of 
reperfusion and then decreased gradually 
to 1.1± 0.2 mg/dl by 14 days of 
reperfusion. The mean serum creatinine 
levels in the treatment group (base line 
levels 0.9± 0.2 mg/dl ) increased to 1.7± 
0.1 mg/dl after 3 days of reperfusion and 
then decreased gradually to 1.1± 0.1mg/dl 
by 14 days of reperfusion (Figure 1). 
However, there was no statistically 
significant difference in the mean serum 
creatinine levels between the control and 
treatment group.  
 
The mean serum BUN levels in the control 
group (base line levels 14.4 ± 1.7 mg/dl) 
increased significantly to 23.5 ± 1.2 by 14 
days of reperfusion (Figure 2). The mean 
serum BUN levels in the treatment group 
(base line levels 14.9 ± 1.3 mg/dl) 
increased to 20.1 ±0.8 mg/dl after 3 days 
of reperfusion and then decreased 
gradually to 14.6 ± 1.4 mg/dl by 14 days 
of reperfusion .There was statistically 
significant difference in the mean serum 
BUN levels between the treatment groups  

















Figure1: Changes in creatinine 
concentration after renal ischemia-
reperfusion of kidneys subjected to 45 
minutes of ischemia (values expressed as 



















Figure 2: Changes in BUN concentration 
after renal ischemia-reperfusion of kidneys 
subjected to 45 minutes of ischemia 




(values expressed as the mean with 
Standard Deviation).  
 
DISCUSSION 
 In the present study the effects of ascorbic 
acid pre-treatment on the kidney damage 
after induction of renal ischemia followed 
by reperfusion was examined in dogs 
using changes in BUN and creatinine as 
indices of renal function.  
 
Ascorbic acid, a water soluble antioxidant 
that reduces reactive oxidant radicals was 
used in an attempt to recover or mitigate 
the renal dysfunction by ischemia 
reperfusion injury. Changes of BUN and 
creatinine were evaluated following 
ischemia reperfusion injury. 
Significant changes in BUN levels (p< 
0.05) were observed in the control group 
when the pre-treatment and 14 days post 
treatment values, 14.4±1.7 mg/dl and 
23.5±1.2 mg/dl respectively, were 
compared. In the treatment group, there 
was no significant difference between 
treatment and 14 days post treatment 
values (14.9±1.3 mg/dl and 20.1±0.8 
mg/dl respectively). These findings 
confirm that renal tissue damage has 
occurred due to ischemia-reperfusion 
injury and it is in agreement with the 
findings of previous authors-Sekhon et al. 
(2003) and Jae-il et al. (2006a). 
 
The observed significant changes in BUN 
levels demonstrated in the control group 
was also in line with the findings of 
Sekhon et al. (2003) and Jae-il et al. 
(2006a). The reasons for these findings are 
most probably due to the greater and 
irreversible damages done to the distal 
segments of the proximal tubules as 
compared to the lesser and reversible 
damage suffered by the more proximal 
segments following ischemia reperfusion . 
The resultant necrosis at the proximal 
segments which is considered the basis for 
the decrease in the function as indicated by 
a significant increased in BUN levels. 
 
In this study, the kidneys were subjected to 
45 minutes of ischemia and ascorbic acid 
pre-treatment at a dose of 150 mg/kg. Our 
findings compared favourably with that of 
Jae-il et al. (2006a) who also observed a 
significant but not abrupt increase in BUN 
levels in the control group 5 days post 
treatment. The severity of the changes in 
BUN levels demonstrated however, did 
not compare favourably with the findings 
of Sekhon et al. (2003) in which ischemia 
period of 90 minutes was used. 
 
Serum creatinine levels were not 
significantly different in both control and 
treatment groups in this study. This is 
because it is possible that creatinine 
diffuses slowly than does BUN ( Jae-il et 
al., 2006a ) and its production is much 
more stable since it depends on intact 
muscles mass ( Michell, 1980 ). The 
production of creatinine is also not easily 
influenced by factors affecting urea 
formation (Osborne et al., 1972).  
 
In conclusion, ascorbic acid has effect on 
renal tissue damage by ischemia 
reperfusion injury in protecting the tissue 
from the effect of ischemia reperfusion 
injury; This may be done by removing free 
radical intermediates and inhibit other 
oxidation reactions by being oxidized 
themselves to a stable and un-reactive 
form that do not cause cellular damage 
(Derek, 1996), thereby helping in the 
recovery of renal function. Also the use of 
BUN as an indicator for evaluating renal 
function in ischemia reperfusion injury 
could be taken to be reliable when 
compared to use of creatinine. 
 
Forty-five (45) minutes of ischemia-
reperfusion appeared short for studies 
aimed at evaluating the influence of 
ascorbic acid on renal function. It is our 
opinion that longer period is used for 
further studies.  
 
Also the influence of the long term post 
operatively administration of ascorbic acid 




needs to be studied. The prospect of the 
use of a higher dose of antioxidant to 
mitigate the effect of ischemia-reperfusion 
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